EP3330383
GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.10.2009EP published:
12.2.2020EP application number:
17194587.6
EPO information:
European Patent Register
Max expiry date:
12.10.2029
Title:
GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER
Timeline
Today
13.10.2009EP application
12.2.2020EP Publication
Owner
Name:
Geron CorporationAddress:
919 E. Hillsdale Blvd., Foster City, CA 94404, US
Inventor
Name:
HARLEY, Calvin, B.Address:
Murphys, CA 95247, US
Name:
ELIAS, LaurenceAddress:
Berkeley, CA 94705, US
Name:
SMITH, JenniferAddress:
Menlo Park, CA 94025, US
Name:
RATAIN, Mark J.Address:
Chicago, IL 60657, US
Name:
BENEDETTI, FabioAddress:
San Francisco, CA 94105, US
Priority
Number:
106491 PDate:
17.10.2008Country:
US
Classification
Categories:
C12N 15/113, C12Q 1/6813, C12Q 1/6883